Malaysian device system targets total life cycle regulation
This article was originally published in Clinica
Executive Summary
Malaysia’s one-year transition to a new risk-based medical device regulatory system – founded in GHTF concepts and designed to facilitate trade as well as ensuring quality and safety – is well under way. The first deadline (compliance with Act 738 - Medical Device Establishment Act) ended on 1 July 2014. Medical Device Authority (MDA) chief executive Zamane bin Abdul Rahman outlined the new regulatory requirements, and who is affected, at the recent Informa Life Sciences Asia Pacific conference
You may also be interested in...
Malaysia Moves: Asian Medtech Associations Regulatory Networking November 2017, Part I
The second Asian Medtech Associations Regulatory Networking discussion focused on a range of regional issues, including the latest on-the-ground news and views. Hosted by Medtech Insight, and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), the Asia Regulatory Professionals Association (ARPA) and Medtronic, this session is reported in two parts, with this first part focusing on Malaysia.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.